Corneal Confocal Microscopy Detects Small-Fiber Neuropathy in Burning Mouth Syndrome: A Cross-Sectional Study

Aims: To assess the utility of corneal confocal microscopy in identifying small fiber damage in patients with burning mouth syndrome (BMS). Methods: A prospective cross-sectional cohort study was conducted at two United Kingdom dental hospitals between 2014 and 2017. A total of 17 consecutive patients with idiopathic BMS aged between 18 and 85 years and 14 healthy age-matched control subjects were enrolled in this study. Corneal subbasal nerve plexus measures were quantified in images acquired using a laser-scanning in vivo corneal confocal microscope. The main outcome measures were corneal nerve fiber density, nerve branch density, nerve fiber length, and Langerhans cell density. Results: Of the 17 patients with BMS, 15 (88%) were women, and the mean (standard deviation) age of the sample was 61.7 (6.5) years. Of the healthy controls, 7 (50%) were women, and the mean (standard deviation) age was 59.3 (8.68) years. Corneal nerve fiber density (no./mm2) (BMS: 29.27 ± 6.22 vs controls: 36.19 ± 5.9;median difference = 6.71; 95% CI: 1.56 to 11.56; P = .007) and corneal nervefiber length (mm/mm2) (BMS: 21.06 ± 4.77 vs controls: 25.39 ± 3.91; median difference = 4.5; 95% CI: 1.22 to 6.81; P = .007) were significantly lower in BMS patients compared to controls, and Langerhans cell density (no./mm2) (BMS:74.04 ± 83.37 vs controls: 29.17 ± 45.14; median difference = –21.27; 95% CI:–65.35 to –2.91; P = .02) was significantly higher. Conclusion: Using a rapid noninvasive ophthalmic imaging technique, this study provides further evidence for small fiber damage in BMS and has potential utility for monitoring disease progression and/or response. Furthermore, this technique shows a hitherto undocumented increased density of immune cells in this group of patients.

burning mouth syndrome;corneal confocal microscopy

1. Acharya S, Carlén A, Wenneberg B, Jontell M, Hägglin C. Clinical characterization of women with burning mouth syndrome in a case-control study. Acta Odontol Scand 2018;76:279–286.

2. Adamo D, Sardella A, Varoni E, et al. The association be- tween burning mouth syndrome and sleep disturbance: A case-control multicentre study. Oral Dis 2018;24:638–649.

3. Braud A, Boucher Y. The relationship between the clinical fea- tures of idiopathic burning mouth syndrome and self-perceived quality of life. J Oral Sci 2016;58:475–481.

4. Bergdahl M, Bergdahl J. Burning mouth syndrome: Prevalence and associated factors. J Oral Pathol Med 1999;28:350 354.

5. Coculescu EC, Tovaru S, Coculescu BI. Epidemiological and etiological aspects of burning mouth syndrome. J Med Life

2014;7:305–309.

6. Chimenos-Küstner E, de Luca-Monasterios F, Schemel- Suárez M, Rodríguez de Rivera-Campillo ME, Pérez-Pérez AM, López-López J. Burning mouth syndrome and associated factors: A case-control retrospective study. Med Clin (Barc) 2017;148:153–157.

7. Nasri-Heir C, Shigdar D, Alnaas D, Korczeniewska OA, Eliav R, Heir GM. Primary burning mouth syndrome: Literature re- view and preliminary findings suggesting possible association with pain modulation. Quintessence Int 2017:49–60.

8. Borsani E, Majorana A, Cocchi MA, et al. Epithelial expres- sion of vanilloid and cannabinoid receptors: A potential role in burning mouth syndrome pathogenesis. Histol Histopathol 2014;29:523–533.

9. Puhakka A, Forssell H, Soinila S, et al. Peripheral nervous sys- tem involvement in primary burning mouth syndrome—Results of a pilot study. Oral Dis 2016;22:338–344.

10. Khan SA, Keaser ML, Meiller TF, Seminowicz DA. Altered structure and function in the hippocampus and medial pre- frontal cortex in patients with burning mouth syndrome. Pain 2014;155:1472–1480.

11. Feller L, Fourie J, Bouckaert M, Khammissa RAG, Ballyram R, Lemmer J. Burning mouth syndrome: Aetiopathogenesis and prin- ciples of management. Pain Res Manag 2017;2017:1926269.

12. Koike K, Shinozaki T, Hara K, et al. Immune and endocrine function in patients with burning mouth syndrome. Clin J Pain 2014;30:168–173.

13. Aljanobi H, Sabharwal A, Krishnakumar B, Kramer JM. Is it Sjögren’s syndrome or burning mouth syndrome? Distinct pa- thoses with similar oral symptoms. Oral Surg Oral Med Oral Pathol Oral Radiol 2017;123:482–495.

14. de Souza IF, Mármora BC, Rados PV, Visioli F. Treatment mo- dalities for burning mouth syndrome: A systematic review. Clin Oral Investig 2018;22:1893–1905.

15. Varoni EM, Lo Faro AF, Lodi G, Carrassi A, Iriti M, Sardella A. Melatonin treatment in patients with burning mouth syndrome: A triple-blind, placebo-controlled, crossover randomized clini- cal trial. J Oral Facial Pain Headache 2018;32:178–188.

16. Zoric B, Jankovic L, Kuzmanovic Pficer J, Zidverc-Trajkovic J, Mijajlovic M, Stanimirovic D. The efficacy of fluoxe- tine in BMS—A cross-over study. Gerodontology 2018; 35:123–128.

17. Azzi L, Croveri F, Pasina L, et al. A burning therapy for burning mouth syndrome: Preliminary results with the administration of topical capsaicin. J Biol Regul Homeost Agents 2017;31 (2, suppl):s89–s95.

18. Lauria G, Majorana A, Borgna M, et al. Trigeminal small-fiber sensory neuropathy causes burning mouth syndrome. Pain 2005;115:332–337.

19. Yilmaz Z, Renton T, Yiangou Y, et al. Burning mouth syndrome as a trigeminal small fibre neuropathy: Increased heat and capsaicin receptor TRPV1 in nerve fibres correlates with pain score. J Clin Neurosci 2007;14:864–871.

20. Honda M, Iida T, Kamiyama H, et al. Mechanical sensitivity and psychological factors in patients with burning mouth syn- drome. Clin Oral Investig 2019;23:757–762.

21. Müller LJ, Vrensen GF, Pels L, Cardozo BN, Willekens B. Architecture of human corneal nerves. Invest Ophthalmol Vis Sci 1997;38:985–994.

22. Kalteniece A, Ferdousi M, Adam S, et al. Corneal confo- cal microscopy is a rapid reproducible ophthalmic tech- nique for quantifying corneal nerve abnormalities. PloS One 2017;12:e0183040.

23. Petropoulos IN, Alam U, Fadavi H, et al. Corneal nerve loss detected with corneal confocal microscopy is symmetrical and related to the severity of diabetic polyneuropathy. Diabetes Care 2013;36:3646–3651.

24. Malik RA, Kallinikos P, Abbott CA, et al. Corneal confocal mi- croscopy: A non-invasive surrogate of nerve fibre damage and repair in diabetic patients. Diabetologia 2003;46:683–688.

25. Kalteniece A, Ferdousi M, Petropoulos I, et al. Greater corneal nerve loss at the inferior whorl is related to the presence of diabetic neuropathy and painful diabetic neuropathy. Sci Rep 2018;8:3283.

26. Stettner M, Hinrichs L, Guthoff R, et al. Corneal confocal mi- croscopy in chronic inflammatory demyelinating polyneuropa- thy. Ann Clin Transl Neurol 2016;3:88–100.

27. Tavakoli M, Marshall A, Banka S, et al. Corneal confocal micros- copy detects small-fiber neuropathy in Charcot-Marie-Tooth disease type 1A patients. Muscle Nerve 2012;46:698–704.

28. Tavakoli M, Marshall A, Pitceathly R, et al. Corneal confocal mi- croscopy: A novel means to detect nerve fibre damage in idio- pathic small fibre neuropathy. Exp Neurol 2010;223:245–250.

29. Tavakoli M, Marshall A, Thompson L, et al. Corneal con- focal microscopy: A novel noninvasive means to diagnose neuropathy in patients with Fabry disease. Muscle Nerve 2009;40:976–984.

30. Tavakoli M, Boulton AJ, Efron N, Malik RA. Increased Langerhan cell density and corneal nerve damage in diabetic patients: Role of immune mechanisms in human diabetic neu- ropathy. Cont Lens Anterior Eye 2011;34:7–11.

31. Bitirgen G, Akpinar Z, Malik RA, Ozkagnici A. Use of corne- al confocal microscopy to detect corneal nerve loss and in- creased dendritic cells in patients with multiple sclerosis. JAMA Ophthalmol 2017;135:777–782.

32. Kass-Iliyya L, Javed S, Gosal D, et al. Small fiber neuropa- thy in Parkinson’s disease: A clinical, pathological and cor- neal confocal microscopy study. Parkinsonism Relat Disord 2015;21:1454–1460.

33. Alam U, Jeziorska M, Petropoulos IN, et al. Diagnostic utility of corneal confocal microscopy and intra-epidermal nerve fibre density in diabetic neuropathy. PLoS One 2017;12:e0180175.

34. Brines M, Culver DA, Ferdousi M, et al. Corneal nerve fiber size adds utility to the diagnosis and assessment of therapeu- tic response in patients with small fiber neuropathy. Sci Rep 2018;8:4734.

35. Chen X, Graham J, Dabbah MA, et al. Small nerve fi- ber quantification in the diagnosis of diabetic senso- rimotor polyneuropathy: Comparing corneal confocal microscopy with intraepidermal nerve fiber density. Diabetes Care 2015;38:1138–1144.

36. Pritchard N, Edwards K, Russell AW, Perkins BA, Malik RA, Efron N. Corneal confocal microscopy predicts 4-year inci- dent peripheral neuropathy in type 1 diabetes. Diabetes Care 2015;38:671–675.

37. Edwards K, Pritchard N, Dehghani C, et al. Corneal confocal microscopy best identifies the development and progression of neuropathy in patients with type 1 diabetes. J Diabetes Complications 2017;31:1325–1327.

38. Tavakoli M, Mitu-Pretorian M, Petropoulos IN, et al. Corneal confocal microscopy detects early nerve regeneration in di- abetic neuropathy after simultaneous pancreas and kidney transplantation. Diabetes 2013;62:254–260.

39. Jääskeläinen SK. Is burning mouth syndrome a neuropathic pain condition? Pain 2018;159:610–613.

40. Srinivasan M, Kodumudi KN, Zunt SL. Soluble CD14 and toll-like receptor-2 are potential salivary biomarkers for oral lichen planus and burning mouth syndrome. Clin Immunol 2008;126:31–37.

41. Casanova-Molla J, Morales M, Planas-Rigol E, et al. Epidermal Langerhans cells in small fiber neuropathies. Pain 2012;153:982–989.